SFX by Ex Libris Inc.

Title:	A phage display selected Fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes
Source:	Gene Therapy [0969-7128] Willemsen, RA yr:2001

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Norkin, L C C. "Simian virus 40 infection via MHC class I molecules and caveolae." Immunological reviews 168.1: 13-22.
description	2.	Pule, Martin A. "Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma." Nature Medicine 14.11 (2008): 1264-70.
description	3.	Klingbeil, Michele M. "Unraveling the secrets of regulating mitochondrial DNA replication." Molecular cell 35.4 (2009): 398-400.
description	4.	Mañes, S. "PATHOGENS: RAFT HIJACKERS." Nature reviews. Immunology 3.7 (2003): 557-568.
description	5.	Schumacher, Ton N M N. "T-cell-receptor gene therapy." Nature reviews. Immunology 2.7 (2002): 512-9.
description	6.	Savoldo, B. "Epstein Barr virus-specific cytotoxic T lymphocytes expressing the anti-CD30 xi artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease." Blood 110.7 (2007): 2620-2630.
description	7.	Rubinstein, P. "Loss of T cell-mediated antitumor immunity after construct-specific downregulation of retrovirally encoded T-cell receptor expression in vivo." Cancer gene therapy 16.2 (2009): 171-183.
description	8.	Pule, M. "Artificial T-cell receptors." Cytotherapy 5.3 (2003): 211-26.
description	9.	Peggs, Karl S S. "Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses." Blood 103.4 (2004): 1548-56.
description	10.	Klingbeil, B. "Stem-loop silencing reveals that a third mitochondrial DNA polymerase, POLID, is required for kinetoplast DNA replication in trypanosomes." Eukaryotic cell 7.12 (2008): 2141-6.
description	11.	van der Veken, Lars T T. "Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity." Cancer research 66.6 (2006): 3331-7.
description	12.	Weiss, A. "Jurkat T cells and development of the T-cell receptor signalling paradigm." Nature reviews. Immunology 4.4: 301-308.
description	13.	Aelion, C Marjorie M. "Soil metal concentrations and toxicity: Associations with distances to industrial facilities and implications for human health." The Science of the total environment 407.7 (2009): 2216-23.
description	14.	Baize, S. "Inflammatory responses in Ebola virus-infected patients." Clinical and experimental immunology 128.1 (2002): 163-8.
description	15.	Montefiori, David C C. "Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines." Journal of virology 79.16 (2005): 10103-10107.
description	16.	Jones, E Yvonne Y. "MHC class II proteins and disease: a structural perspective." Nature reviews. Immunology 6.4: 271-282.
description	17.	Homann, D. "To help and help not." Nature immunology 5.9 (2004): 878-80.
description	18.	Xue, E. "Exploiting T cell receptor genes for cancer immunotherapy." Clinical and experimental immunology 139.2 (2005): 167-72.
description	19.	Ogretmen, B. "Biologically active sphingolipids in cancer pathogenesis and treatment." Nature reviews. Cancer 4.8 (2004): 604-16.
description	20.	Triantafilou, K. "Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation." Journal of cell science 115.12: 2603-2611.